22.27
前日終値:
$22.24
開ける:
$22.2
24時間の取引高:
570.37K
Relative Volume:
0.97
時価総額:
$1.73B
収益:
$1.53B
当期純損益:
$40.23M
株価収益率:
44.54
EPS:
0.5
ネットキャッシュフロー:
$60.93M
1週間 パフォーマンス:
+1.09%
1か月 パフォーマンス:
-8.20%
6か月 パフォーマンス:
+27.48%
1年 パフォーマンス:
-37.76%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
名前
Integra Lifesciences Holdings Corp
セクター
電話
(609) 275-0500
住所
1100 CAMPUS ROAD, PRINCETON, NJ
IART を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IART
Integra Lifesciences Holdings Corp
|
22.27 | 1.73B | 1.53B | 40.23M | 60.93M | 0.50 |
![]()
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-02 | 開始されました | Morgan Stanley | Underweight |
2024-10-07 | アップグレード | BTIG Research | Sell → Neutral |
2024-07-30 | ダウングレード | BTIG Research | Neutral → Sell |
2024-07-30 | ダウングレード | Citigroup | Neutral → Sell |
2024-05-07 | ダウングレード | Oppenheimer | Outperform → Perform |
2024-05-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2024-04-03 | アップグレード | Citigroup | Sell → Neutral |
2023-12-05 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2023-11-14 | 開始されました | CL King | Buy |
2023-08-24 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2023-07-12 | アップグレード | Jefferies | Hold → Buy |
2023-06-08 | ダウングレード | Argus | Buy → Hold |
2023-05-24 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-05-23 | ダウングレード | Citigroup | Neutral → Sell |
2022-10-12 | 開始されました | Jefferies | Hold |
2022-07-25 | 開始されました | Morgan Stanley | Equal-Weight |
2022-04-13 | ダウングレード | Truist | Buy → Hold |
2021-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
2021-09-15 | ダウングレード | BTIG Research | Buy → Neutral |
2020-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
2020-05-27 | 開始されました | Citigroup | Neutral |
2020-04-03 | 開始されました | SunTrust | Buy |
2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
2019-01-03 | 開始されました | SunTrust | Buy |
2018-11-28 | 開始されました | UBS | Neutral |
2018-08-07 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2018-07-26 | アップグレード | BTIG Research | Neutral → Buy |
2018-07-02 | ダウングレード | Citigroup | Buy → Neutral |
2018-01-05 | 再開されました | Cantor Fitzgerald | Neutral |
2018-01-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
2017-11-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-10-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
2017-10-27 | ダウングレード | JP Morgan | Overweight → Neutral |
2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
2017-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-01-13 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-01-06 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
2016-12-12 | 開始されました | UBS | Buy |
すべてを表示
Integra Lifesciences Holdings Corp (IART) 最新ニュース
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Yahoo Finance
Integra LifeSciences Holdings Corp. to Host Earnings Call - ACCESS Newswire
Amalgamated Bank Has $440,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - SETE News
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Trading Up 5.1%Time to Buy? - MarketBeat
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Investor Network: INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call - ACCESS Newswire
Integra LifeSciences Holdings Corp Releases 2024 Form 10-K Report: A Comprehensive Analysis of Financial Performance, Business Strategy, and Market Challenges - HPBL
Integra LifeSciences maintains $35 target, Market Outperform rating By Investing.com - Investing.com South Africa
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ... - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORP SEC 10-K Report - TradingView
Integra LifeSciences (IART) Stock Rises on Strong Q4 Results - GuruFocus.com
Integra LifeSciences Stock Surges 13.6% Post Q4 2024 ResultsNews and Statistics - IndexBox, Inc.
Integra: Q4 Earnings Snapshot - The Washington Post
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Integra LifeSciences Q4 2024 EPS beats, stock rises - Investing.com
Integra LifeSciences Guides FY25 In Line With View; Q4 Adj. EPS Tops Estimates - Nasdaq
INTEGRA LIFESCIENCES HLDGS Earnings Results: $IART Reports Quarterly Earnings - Nasdaq
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue Estimates - Yahoo Finance
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance - Yahoo Finance
Integra Lifesciences Q4 2024 Earnings: EPS Misses at $0.25, Reve - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Repor - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
INTEGRA LIFESCIENCES HLDGS Earnings Preview: Recent $IART Insider Trading, Hedge Fund Activity, and More - Nasdaq
Empowered Funds LLC Takes Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences (IART) to Release Earnings on Tuesday - Defense World
SHAREHOLDER ALERT: Morris Kandinov Investigating VG, ADSK, DKS, and IART; Shareholders are Encouraged to Contact the Firm - GlobeNewswire Inc.
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IART 12-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - ACCESS Newswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences ... - The Bakersfield Californian
Integra LifeSciences (NASDAQ:IART) Shares Down 5.3%What's Next? - MarketBeat
Shareholders in Integra LifeSciences Holdings (NASDAQ:IART) have lost 63%, as stock drops 4.1% this past week - Yahoo Canada Finance
Choreo LLC Acquires 5,123 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences (NASDAQ:IART) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Grabar Law Office is Investigating Claims on Behalf of - GlobeNewswire
Wound Closure Strips Market to Grow by USD 102.8 Million from 2025-2029, Driven by Focus on Reducing SSIs, Report with Market Evolution Powered by AITechnavio - The Malaysian Reserve
EVP, Chief Legal Officer & Sec, Schwartz Eric sold 4,070 shares of Integra Lifesciences Holdings Corp [IART] - Knox Daily
Integra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest Down 6.1% in January - MarketBeat
Notice To Long-Term Integra Lifesciences Holdings - GlobeNewswire
Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Hamilton Spectator
Ready to Jump After Recent Trade: Integra Lifesciences Holdings Corp (IART) - SETE News
Integra LifeSciences to Release Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 - Yahoo Finance
Global Dental Surgery Instrument Market Regional Analysis [2025-2033] | 107 Pages Modern Report - WICZ
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) PT at $23.00 - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Rating of “Reduce” from Brokerages - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Stock Holdings Decreased by Assenagon Asset Management S.A. - Defense World
Integra Lifesciences Holdings Corp (IART) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):